The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOsirium Tech Regulatory News (OSI)

  • This share is currently suspended. It was suspended at a price of 2.20

Share Price Information for Osirium Tech (OSI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.20
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.00
OSI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) Osirium Technologies plc

5 Sep 2023 07:00

RNS Number : 3440L
Osirium Technologies PLC
05 September 2023
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Osirium Technologies plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Osirium Technologies plc

(d) Is the discloser the offeror or the offeree?

Offeree

 

(e) Date position held:

The latest practicable date prior to the disclosure

4 September 2023

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

-

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(A) Ordinary shares of 1 pence each ("Ordinary Shares") held by directors of Osirium Technologies plc and their close relatives:

 

 

Name

Number of Ordinary Shares held

% of Ordinary Shares held

Simon Lee

1,656,083

1.35%

David Guyatt1

9,913,109

8.09%

Stuart McGregor

896,523

0.73%

Rupert Hutton2

1,140,580

0.93%

Simon Hember

103,571

0.08%

 

1Total holdings of David Guyatt and close family members

2Total holdings of Rupert Hutton and close family members

 

 

 

(B) Options held by Osirium Technologies plc directors and their close relatives in Osirium Technologies plc's Ordinary Shares:

 

 

Name

Granted

Number of options over Ordinary Shares held

Exercise price

Scheme

Vesting period

Expiry date

Stuart McGregor

19 May 2023

3,676,460

2 pence

Enterprise Management Incentive (EMI) Share Option Plan 2020-2025

3 years

18 May 2033

Rupert Hutton

19 May 2023

1,225,487

2 pence

Enterprise Management Incentive (EMI) Share Option Plan 2020-2025

3 years

18 May 2033

Catherine Jamieson

19 May 2023

612,743

2 pence

Enterprise Management Incentive (EMI) Share Option Plan 2020-2025

3 years

18 May 2033

Tom Guyatt

19 May 2023

612,743

2 pence

Enterprise Management Incentive (EMI) Share Option Plan 2020-2025

3 years

18 May 2033

 

(c) Interests of persons acting in concert with Osirium Technologies plc (in addition to those set out in (a) above) in the Osirium Technologies plc's Ordinary Shares

 

Name

Number of ordinary

shares held

% of voting share capital

Allenby Capital Limited

1,625,950

1.33%

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 September 2023

Contact name:

Rupert Hutton, Chief Financial Officer

Telephone number:

+44 (0)1183 242 444

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEKZGGLGDZGFZZ
Date   Source Headline
15th Oct 20207:00 amRNSContract win with leading healthcare provider
8th Oct 20207:00 amRNSCompetitive contract win with major UK Retailer
29th Sep 20207:00 amRNSInterim Results
21st Sep 20207:00 amRNSNotice of Results
16th Jun 202012:00 pmRNSResult of AGM
15th May 20207:00 amRNSFinal Results
8th Apr 20207:00 amRNSCOVID-19 Update and Contract Renewal
17th Mar 20207:00 amRNSContract win with major regional Ambulance Service
24th Feb 20203:46 pmRNSHolding(s) in Company
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
20th Feb 20207:00 amRNSContract win with major regional NHS Trust
14th Jan 20207:00 amRNSTrading Update
11th Dec 20197:00 amRNSLaunch of Privileged Endpoint Manager solution
14th Nov 20195:25 pmRNSHolding(s) in Company
31st Oct 201910:48 amRNSTotal Voting Rights
30th Oct 201911:35 amRNSHolding(s) in Company
29th Oct 201912:09 pmRNSHolding(s) in Company
22nd Oct 20197:00 amRNSResult of fundraise
21st Oct 20197:00 amRNSProposed fundraise
10th Oct 20197:00 amRNSNew customer and upsell contract wins
23rd Sep 20197:00 amRNSSubstantial contract win
18th Sep 20197:00 amRNSHalf Year Report
10th Sep 20191:27 pmRNSNotice of Results
14th Aug 20197:00 amRNSFirst contract win for Opus
7th Aug 20197:00 amRNSContract wins
8th Jul 20197:00 amRNSTrading update
13th Jun 201912:07 pmRNSResult of AGM
6th Jun 20197:00 amRNSContract win
4th Jun 20197:00 amRNSInfosecurity Europe 2019
29th May 20197:00 amRNSHolding(s) in Company
17th May 20197:00 amRNSContract Extension
8th May 20197:00 amRNSFinal Results
1st May 20197:00 amRNSLaunch of secure IT Process Automation solution
29th Apr 20197:00 amRNSNotice of Final Results
18th Apr 20194:05 pmRNSHolding(s) in Company
22nd Mar 20194:30 pmRNSHolding(s) in Company
27th Feb 20197:00 amRNSContract wins
12th Feb 20197:00 amRNSContract win
14th Jan 20197:00 amRNSTrading Update
9th Jan 20191:59 pmRNSHolding(s) in Company
8th Jan 20197:00 amRNSContract win with major Business Energy player
19th Dec 20187:00 amRNSContract win with Financial Services provider
5th Oct 20187:00 amRNSGrant of options and PDMR dealings
25th Sep 20187:00 amRNSInterim results
21st Sep 20187:00 amRNSContract win with UK Fashion and Homeware Retailer
19th Sep 20187:00 amRNSStrategic Technology Partnership with RazorSecure
6th Aug 20187:00 amRNSNotice of Interim Results
24th May 201811:31 amRNSResult of AGM
14th May 201810:39 amRNSHolding(s) in Company
24th Apr 20187:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.